SEVERE AORTIC STENOSIS – TAVI OR SURGERY

Hoàng Tài My Nguyễn , Ích Trung Lý, Thượng Nghĩa Nguyễn

Main Article Content

Abstract

Aortic valve stenosis demonstrates a rising prevalence in tandem with the aging demographic. Across numerous studies and progressively broadening indications from the high-risk patients to the patients with lower risk, transcatheter aortic valve replacement (TAVI) has supplanted surgery in terms of quantity. What are its merits, extant dilemmas, and forthcoming obstacles?

Article Details

References

1. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013 Sep 10;62(11): 1002-12. doi: 10.1016/j.jacc.2013.05.015. Epub 2013 May 30. PMID: 23727214.
2. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 2 avr 1988;9(suppl E):57‐64.
3. Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, et al. The effect of aortic valve replacement on survival. Circulation. nov 1982;66(5):1105‐10.
4. Desai PV, Goel SS, Kleiman NS, Reardon MJ. Transcatheter Aortic Valve Implantation: Long-Term Outcomes and Durability. Methodist DeBakey Cardiovasc J. 2023;19(3):15-25. doi: 10.14797/mdcvj.1201
5. Windecker S, Okuno T, Unbehaun A, Mack M, Kapadia S, Falk V. Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? Eur Heart J. 2022 Aug 1;43(29):2729-2750. doi: 10.1093/ eurheartj/ehac105. PMID: 35466382.
6. Ali N, Hildick-Smith D, Parker J, et al. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry. Catheter Cardiovasc Interv. 2023; 101: 932-942. doi:10.1002/ccd.30627
7. Hans Gustav Hørsted Thyregod, Troels Højsgaard Jørgensen, Nikolaj Ihlemann, et al., Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial, European Heart Journal, 2024;, ehae043, https://doi.org/10.1093/eurheartj/ehae043
8. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17. Erratum in: Circulation. 2021 Feb 2;143(5):e228. Erratum in: Circulation. 2021 Mar 9;143(10):e784. PMID: 33332149.